Pharmacogenomics of Antihypertensive Drugs in Brazil: Recent Progress and Clinical Implications.
Endocr Metab Immune Disord Drug Targets
; 22(13): 1263-1275, 2022.
Article
in En
| MEDLINE
| ID: mdl-34951375
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pharmacogenetics
/
Hypertension
/
Antihypertensive Agents
Type of study:
Prognostic_studies
Limits:
Female
/
Humans
/
Pregnancy
Country/Region as subject:
America do sul
/
Brasil
Language:
En
Journal:
Endocr Metab Immune Disord Drug Targets
Journal subject:
ALERGIA E IMUNOLOGIA
/
ENDOCRINOLOGIA
/
METABOLISMO
/
TERAPIA POR MEDICAMENTOS
Year:
2022
Type:
Article
Affiliation country:
Brazil